Compare NextEra Energy, Inc. (NEE) vs Oruka Therapeutics Inc. Common Stock (ORKA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NextEra Energy, Inc. vs Oruka Therapeutics Inc. Common Stock — how do they compare? NextEra Energy, Inc. trades at $79.29 (market cap $163.17B), while Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B). The key difference: NextEra Energy, Inc. is far larger — about 31.5× Oruka Therapeutics Inc. Common Stock's market cap, and NextEra Energy, Inc. pays a 3.19% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NextEra Energy, Inc. for 83 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.
| NEE | ORKA | |
|---|---|---|
Market Cap | $163.17B | $5.18B |
Volume | 9,492,162 | 490,798 |
Sector | Utilities | Health |
52-Week High | $97.88 | $113.08 |
52-Week Low | $75.49 | $26.19 |
Typical Hold Time | 83 Days | 0 Days |
Enterprise Value | $270.50B | $4.31B |
Dividend Yield | 3.19% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NextEra Energy (NEE) trades at $78.22, down 0.37% on the day, with a bullish technical signal despite mixed indicators. The stock shows strong fundamentals with a P/E of 17.58, net income margin of 32.4%, and recent earnings beats in Q1 and Q2 2026. Recent news highlights growth initiatives, including a $22.3 billion energy infrastructure project in Texas, positioning the company for expansion amid a 66.66% analyst buy rating.
Outlook remains positive with a consensus price target of $95.60, offering ~22% upside. Key risks include rising debt-to-asset ratios (47.6% in 2025) and interest rate sensitivity. Investors should weigh strong profitability against capital expenditure demands and macroeconomic pressures.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About NextEra Energy, Inc.
NextEra Energy's regulated utility, Florida Power & Light, distributes power to more than 5 million customers in Florida. FP&L contributes more than 60% of the group's operating earnings. The renewable energy segment generates and sells power throughout the United States and Canada. Consolidated generation capacity totals more than 50 gigawatts and includes natural gas, nuclear, wind, and solar assets.
Read more on NEE →About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →
